“What do you mean it can cure cancer, Noah?”
“It is just as I said, Richard. Vogel has isolated the human gene variant that is related to all allergic and autoimmune diseases. Multiple sclerosis, asthma, Crohn’s disease, celiac disease, and type-1 diabetes can all be done away with across the board, that is, for all human beings everywhere, and for an extremely low-cost.”
Professor Noah David Abramson hadn’t visited the offices of the Synthetic Solutions Corporation’s President and CEO since he’d retired as their Director of the Advanced Research and Development department nearly ten years ago. However on occasion, Richard Underwood called him back as a “special consultant” when they encountered a “unique situation” involving one of SSC’s sentient AI platforms. In this case, the medical AI known as Vogel, commissioned in a joint venture by the National Institutes of Health and the Mayo Clinic, had presented such a circumstance.
“You have no idea what kind of bind this has put me in, Noah.”
“Bind, Richard? You’ll be called the man who cured cancer, although it was really the AI that did it. I would think this would make you not just a hero, but the Person of the Century. Isn’t that what Time magazine would call you? Why you might even win a Nobel.”
“Very funny, Noah. You’ve got several so I can’t imagine you’re impressed.”
“So tell me about your bind, Richard.”
Continue reading →